Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 6.569 Q1 | 391 | 242 | 519 | 7490 | 5967 | 413 | 10.42 | 30.95 |  |
| 2 | Trends in Pharmacological Sciences | journal | 5.544 Q1 | 244 | 80 | 260 | 5902 | 3056 | 246 | 11.90 | 73.78 | |
| 3 | Neuropsychopharmacology | journal | 3.368 Q1 | 249 | 249 | 805 | 16794 | 5537 | 779 | 6.87 | 67.45 | |
| 4 | Natural Product Reports | journal | 3.020 Q1 | 211 | 83 | 210 | 13863 | 1692 | 201 | 7.76 | 167.02 | |
| 5 | Neuropharmacology | journal | 2.355 Q1 | 191 | 225 | 821 | 12830 | 3992 | 813 | 5.12 | 57.02 | |
| 6 | Journal of Antimicrobial Chemotherapy | journal | 2.161 Q1 | 221 | 419 | 1656 | 10729 | 7093 | 1289 | 4.26 | 25.61 | |
| 7 | Particle and Fibre Toxicology | journal | 2.097 Q1 | 119 | 41 | 64 | 2370 | 423 | 60 | 5.58 | 57.80 | |
| 8 | Drug Discovery Today | journal | 2.028 Q1 | 215 | 140 | 452 | 8078 | 3126 | 428 | 6.55 | 57.70 | |
| 9 | Environmental Pollution | journal | 2.002 Q1 | 301 | 475 | 1436 | 21905 | 5928 | 1415 | 3.71 | 46.12 | |
| 10 | International Journal of Neuropsychopharmacology | journal | 1.892 Q1 | 125 | 125 | 335 | 6482 | 1459 | 309 | 4.11 | 51.86 | |
| 11 | Toxicological Sciences | journal | 1.874 Q1 | 207 | 262 | 908 | 12241 | 4658 | 854 | 4.86 | 46.72 | |
| 12 | Antiviral Therapy | journal | 1.852 Q1 | 93 | 147 | 426 | 5522 | 1725 | 418 | 3.67 | 37.56 | |
| 13 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.775 Q1 | 106 | 73 | 219 | 2352 | 680 | 207 | 3.34 | 32.22 | |
| 14 | Journal of Nanobiotechnology | journal | 1.770 Q1 | 109 | 34 | 35 | 1349 | 250 | 33 | 5.25 | 39.68 | |
| 15 | BioDrugs | journal | 1.664 Q1 | 79 | 47 | 119 | 2941 | 576 | 111 | 5.36 | 62.57 | |
| 16 | Current Opinion in Drug Discovery and Development | journal | 1.661 Q1 | 85 | 68 | 221 | 4845 | 1124 | 204 | 5.31 | 71.25 | |
| 17 | Pharmacogenomics Journal | journal | 1.661 Q1 | 95 | 51 | 136 | 2259 | 714 | 133 | 4.63 | 44.29 | |
| 18 | Drug Safety | journal | 1.620 Q1 | 140 | 103 | 311 | 4330 | 1295 | 259 | 4.04 | 42.04 | |
| 19 | Expert Opinion on Therapeutic Targets | journal | 1.594 Q1 | 106 | 109 | 377 | 11083 | 1506 | 363 | 3.95 | 101.68 | |
| 20 | Critical Reviews in Toxicology | journal | 1.546 Q1 | 129 | 43 | 114 | 5878 | 625 | 106 | 4.84 | 136.70 | |
| 21 | Expert Opinion on Drug Delivery | journal | 1.546 Q1 | 133 | 97 | 253 | 9623 | 1281 | 242 | 5.11 | 99.21 | |
| 22 | Clinical Pharmacokinetics | journal | 1.533 Q1 | 184 | 58 | 190 | 4333 | 1017 | 177 | 5.30 | 74.71 | |
| 23 | Tetrahedron | journal | 1.526 Q1 | 236 | 1187 | 3954 | 59908 | 12586 | 3926 | 3.08 | 50.47 | |
| 24 | Clinical Trials | journal | 1.507 Q1 | 74 | 76 | 188 | 1771 | 404 | 153 | 2.13 | 23.30 | |
| 25 | Nanotoxicology | journal | 1.501 Q1 | 107 | 32 | 85 | 1602 | 429 | 82 | 3.54 | 50.06 | |
| 26 | Expert Review of Vaccines | journal | 1.482 Q1 | 105 | 142 | 390 | 10509 | 1531 | 333 | 3.90 | 74.01 | |
| 27 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.438 Q1 | 99 | 27 | 70 | 2257 | 349 | 66 | 4.91 | 83.59 | |
| 28 | Addictive Behaviors | journal | 1.429 Q1 | 149 | 200 | 663 | 7546 | 1905 | 662 | 2.43 | 37.73 | |
| 29 | Expert Opinion on Investigational Drugs | journal | 1.367 Q1 | 117 | 149 | 508 | 11809 | 2156 | 487 | 4.39 | 79.26 | |
| 30 | Journal of Psychopharmacology | journal | 1.351 Q1 | 135 | 231 | 378 | 9785 | 1310 | 326 | 3.14 | 42.36 | |
| 31 | Human Genomics | journal | 1.348 Q1 | 68 | 36 | 53 | 834 | 122 | 43 | 2.30 | 23.17 | |
| 32 | Current Opinion in Molecular Therapeutics | journal | 1.336 Q1 | 67 | 88 | 220 | 5913 | 801 | 203 | 3.88 | 67.19 | |
| 33 | ChemMedChem | journal | 1.294 Q1 | 119 | 211 | 603 | 9609 | 2141 | 592 | 3.38 | 45.54 | |
| 34 | Pharmacogenomics | journal | 1.281 Q1 | 100 | 190 | 537 | 7298 | 1961 | 454 | 3.61 | 38.41 | |
| 35 | Current Opinion in Investigational Drugs | journal | 1.257 Q1 | 83 | 144 | 375 | 10224 | 1330 | 340 | 3.70 | 71.00 | |
| 36 | Expert Opinion on Biological Therapy | journal | 1.256 Q1 | 102 | 147 | 477 | 12860 | 1755 | 468 | 3.73 | 87.48 | |
| 37 | PharmacoEconomics | journal | 1.253 Q1 | 118 | 110 | 258 | 4458 | 813 | 205 | 3.39 | 40.53 | |
| 38 | Pharmaceutical Statistics | journal | 1.250 Q1 | 46 | 33 | 88 | 559 | 152 | 82 | 1.49 | 16.94 | |
| 39 | Mutagenesis | journal | 1.246 Q1 | 102 | 78 | 179 | 3437 | 738 | 173 | 4.24 | 44.06 | |
| 40 | Tetrahedron Letters | journal | 1.245 Q1 | 181 | 1731 | 5607 | 58964 | 15148 | 5606 | 2.68 | 34.06 | |
| 41 | British Journal of Clinical Pharmacology | journal | 1.194 Q1 | 167 | 202 | 734 | 5994 | 2285 | 550 | 3.04 | 29.67 | |
| 42 | Inhalation Toxicology | journal | 1.174 Q1 | 97 | 137 | 411 | 6007 | 1202 | 389 | 2.25 | 43.85 | |
| 43 | Journal of Drug Targeting | journal | 1.152 Q1 | 107 | 83 | 246 | 3686 | 830 | 237 | 2.73 | 44.41 | |
| 44 | Bioorganic and Medicinal Chemistry | journal | 1.083 Q1 | 187 | 891 | 2602 | 33501 | 8613 | 2596 | 3.14 | 37.60 | |
| 45 | Bioorganic and Medicinal Chemistry Letters | journal | 1.080 Q1 | 166 | 1586 | 4100 | 41450 | 11606 | 4098 | 2.83 | 26.13 | |
| 46 | Expert Opinion on Drug Metabolism and Toxicology | journal | 1.043 Q1 | 100 | 121 | 315 | 10240 | 1249 | 310 | 3.82 | 84.63 | |
| 47 | Alcohol and Alcoholism | journal | 1.018 Q1 | 109 | 75 | 323 | 2810 | 919 | 302 | 2.74 | 37.47 | |
| 48 | CNS Neuroscience and Therapeutics | journal | 1.013 Q2 | 91 | 52 | 66 | 4399 | 258 | 63 | 3.91 | 84.60 | |
| 49 | Cardiovascular Therapeutics | journal | 0.996 Q2 | 54 | 59 | 69 | 3319 | 171 | 63 | 2.48 | 56.25 | |
| 50 | Expert Opinion on Emerging Drugs | journal | 0.984 Q2 | 54 | 47 | 133 | 4968 | 471 | 133 | 3.91 | 105.70 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data